Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATS: Methylphenidate in ADHD Preschoolers
NCT00018863Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Apr 2001
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate with Placebo (2 arms). Primary endpoints: Swanson, Kotkin, Atkins, M-Flynn, and Pelham (SKAMP) and Conners, Loney, and Milich (CLAM) Combined Score and Swanson, Nolan, and Pelham Rating Scale. Started Apr 2001; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00018863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018863.